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ABSTRACT The glucocorticoid response element (GRE)
of mouse mammary tumor virus (MMTV) was chemically
synthesized as two complementary DNA strands bearing co-
hesive termini. During automated synthesis, random mutations
were introduced into the DNA by "doping" each of the four
nucleoside phosphoramidites (A, G, C, and T) with a low level
of the other three. These preparations were annealed and
cloned into an M13 phage vector to produce a library of GRE
mutants. Mutations within the synthesized region were iden-
tified by sequencing phage isolates at random. All of the
chemically distinct classes of transition and transversion mu-
tations have been observed. Statistical considerations indicate
that the library contains all of the possible 90 point substitution
mutations within a 30-nucleotide mutagenic target. So far 88 of
these substitutions have been isolated, 74 as single mutants. At
least two of the three possible single mutants at each of the 30
positions have been identified.
Several methods have been developed for introducing de-
fined changes into DNA molecules of known sequence (for
review, see ref. 1). The most precise of these is oligonucle-
otide-directed mutagenesis (2), which has been used to
introduce single base substitutions at specific positions in
DNA sequences as well as specific insertions and deletions.
In fact, the major limitation of the method has been its high
degree of specificity, because the strategies used have usually
required the synthesis of a different mutagenic oligonucleo-
tide for each desired mutation. In situations where it is
necessary to produce many mutations throughout a se-
quenced region, other methods have been used, such as
bisulfite mutagenesis (3) and the linker scanning method (4).
The method of enzymatic nucleotide misincorporation (5)
appears to produce a completely random set of substitution
mutations. Recently, the potential of oligonucleotides as
mutagens has been expanded through the use of mutagenic
oligonucleotides synthesized to contain mixtures of bases at
several positions within a target sequence (6-9). This allowed
a number of different mutations to be introduced by using a
single synthetic oligonucleotide preparation.
We present here a general method for producing and
identifying every possible single base substitution mutation
within a region. As described below, the method requires
synthesis of each strand of the target sequence only once. To
test the feasibility of the method, we have produced muta-
tions within the glucocorticoid response element (GRE) of
mouse mammary tumor virus (MMTV). The GRE resembles
an enhancer that can stimulate expression ofan adjacent gene
in the presence of glucocorticoids (10, 11). Like enhancers,
this activity exhibits some positional and orientational flex-
ibility (12, 13). The GRE is specifically recognized by the
glucocorticoid hormone receptor in vitro (14, 15), an inter-
action that is undoubtedly an integral part of the regulatory
mechanism. Assays of various deletion mutants (12, 13,
16-19), combined with results of receptor-DNA footprint
experiments (14, 15), indicate that a domain of -30 nucleo-
tides (positions -160 to -190 relative to the start of tran-
scription; see Fig. 1) contains a strong receptor binding site
and is critical for activity of the element. We therefore expect
that a combination of in vitro and in vivo assays ofthe mutants
ofthis domain that we have isolated will yield insights into the
sequence specificity of this regulatory element and the
mechanism of steroid-mediated regulation of gene expres-
sion.
The method relies on automated synthesis of the target
sequence in a way that yields a randomly mutagenized
preparation. This is achieved by a slight modification of the
usual synthetic procedure, in which chains are built stepwise
from the 3' end by the addition of nucleoside phosphorami-
dite monomeric units. Before synthesis begins, each of the
four monomer reservoirs is "doped" with a small amount of
each of the other three. Incorporation of a dopant molecule
into the synthetic product results in a mutant sequence. Since
the contaminating nucleotides are incorporated at random,
this procedure results in a population of molecules containing
0, 1, 2, 3, or more mutations. It is possible to control the
number of mutations per molecule by adjusting the compo-
sition of the phosphoramidite mixtures.
After synthesis, the mutagenized sequences are amplified
by biological cloning to produce a mutant "library," a
population containing a large number of single and multiple
mutants of the original sequence. Every viable molecule in
the library contains the synthetic sequence because of the
particular cloning strategy used. Very rapid and convenient
DNA sequencing procedures make it practical to identify
every possible substitution mutation within the mutagenic
target by simply sequencing random isolates from the library.
MATERIALS AND METHODS
Chemical Synthesis of DNA. Synthesis was performed by
using an Applied Biosystems model 380A DNA synthesizer.
We used the standard program cycle supplied with the
machine (ABI001; 7/22/83), which was measured at 18.2
min. All synthetic reagents were also from Applied
Biosystems (Foster City, CA). Standard operating proce-
dures were used except for the preparation of the mutagenic
nucleoside phosphoramidite mixtures. The contents of 0.5-g
bottles of each of the four phosphoramidites were dissolved
in the following amounts of dry acetonitrile injected through
the septum to give 0.13 M solutions (A, 5.8 ml; G, 6.0 ml; C,
6.2 ml; T, 7.0 ml). After the phosphoramidites were com-
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mouse mammary tumor virus.
*Present address: Department of Pathology, University of Colorado
Health Sciences Center, Denver, CO 80262.
710
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Proc. Natl. Acad. Sci. USA 83 (1986) 711
pletely in solution, all four were uncapped. The four solutions
were cross-contaminated by transferring 100 1.l from each
one to each of the other three. This was done quickly with a
Gilson Pipetman P200 without changing tips. The bottles
were covered temporarily with Paraffim (American Can
Company, Greenwich, CT) swirled briefly, and placed on the
machine as quickly as possible by using the bottle changing
routines. This resulted in roughly a 5% impurity in each
phosphoramidite solution, or -1.5% of each of the three
mutagenic species.
The oligonucleotides were detritylated and partially
deprotected automatically by the synthesizer. The oligonu-
cleotides were fully deprotected and purified by chromatog-
raphy on Sephadex G-50 fine, followed by gel electrophore-
sis, using standard procedures (supplied by Applied
Biosystems). A fairly broad segment was excised from the
preparative gel (so that some of the species, one longer and
one shorter than the desired length, were included) to be sure
to include mutant sequences that might have altered mobility.
Cloning. The two complementary oligonucleotides were
mixed at a concentration of 1 pmol/,dl each in TM/16 (TM =
100 mM Tris HCl, pH 8.5/50 mM MgCl2) to give a total vol
of 20 ul, in a 1.5-ml Eppendorf tube. This was floated on 1
liter of water at 100'C, and allowed to cool to room temper-
ature over a period of several hours. Condensation was
collected by briefcentrifugation. This annealing reaction, and
a 1:100 dilution in TM/8 (0.01 pmol/gl) were stored at -20'C.
It should be noted that these oligonucleotides were not
phosphorylated at their 5' termini.
M13 mpll replicative form DNA (20) was simultaneously
digested with approximately a 10-fold excess of HindIII and
Sst I in core buffer (BRL). The digest was phenol-extracted,
ethanol-precipitated, rinsed with ethanol, dried, and dis-
solved in 10mM Tris HCl, pH 8.1/0.1 mM EDTA (TE) buffer
to give a stock at 20 ng/,ul.
One hundred nanograms (0.021 pmol) of digested M13
mpll vector was mixed with 0.042 pmol of annealed oligo-
nucleotide in 50 mM Tris HCl, pH 7.5/10 mM MgCl2/10 mM
dithiothreitol/1 mM ATP/3 units ofT4 DNA ligase (BRL), to
give a total vol of 20 al. This reaction mixture was incubated
overnight at 4°C. The reaction mixture was phenol-extracted,
ethanol-precipitated, rinsed with ethanol, dried, and redis-
solved in 50 ,ul of TE buffer. Six microliters of a solution of
100 mM Tris HCl, pH 7.8/60 mM MgCl2/1.5 M NaCl/2 mM
EDTA/10 mM dithiothreitol was added, plus enough Sal I
and BamHI restriction enzymes to give a 50- to 100-fold
overdigestion of the vector polylinker (58 ,ul total vol). Five
microliters of this digest was used to transfect competent
Escherichia coli strain JM107 (21) prepared by the method of
Hanahan (22).
A plate containing =5000 plaques was washed by overlay-
ing with 4 ml of LB medium for 5 min. The medium was
removed, centrifuged, and samples were stored at 4°C and
-20°C. This is the GRE mutant library used in subsequent
analysis.
DNA Sequencing. Sequencing was performed by the chain-
termination method (23). Very rapid procedures for prepa-
ration of sequencing templates from 1.5-ml cultures, carrying
out sequencing reactions in 96-well microtiter trays, and
running 12 sets of reactions (48 samples) on a 20-cm wide gel
were performed essentially as described to us by Alan
Bankier (Medical Research Council Laboratory of Molecular
Biology, Cambridge, England). These are slight modifica-
tions of the methods described by Bankier and Barrell (24),
and a detailed protocol is available on request. These meth-
ods make it feasible to sequence 48 or more isolates in a day.
One of us (C.A.H. III) sequenced 189 clones from the mutant
library described in this paper in a 10-day period, but a
graduate student should be able to proceed more rapidly. The
ratio of dideoxynucleotides to normal deoxynucleotides was
increased 15-fold above that used for routine sequencing to
facilitate the sequencing of small inserts. A 15-nucleotide
primer, 5' AGTCACGACGTTGTA 3' (Bethesda Research
Laboratories), worked well for sequencing inserts into the
primer proximal end of the M13 mpll polylinker. The
Klenow fragment of E. coli DNA polymerase I was obtained
from Boehringer Mannheim, or from Bethesda Research
Laboratories. The sequencing reactions were radioactively
labeled with dATP [a-35S] (25) obtained from New England
Nuclear, and the products were analyzed on very thin (0.35
mm) 8% polyacrylamide gels (26).
RESULTS AND ANALYSIS
The strategy for synthesis and cloning of the synthetic GRE
is shown in Fig. 1. Two strands were synthesized; one is 40
nucleotides long (GRE.1) with 5' HindIII and 3' Sst I
cohesive ends. The other strand (GRE.2) is 32 nucleotides
long and anneals with GRE.1 to provide the recessed termini
of these two restriction sites. This sequence has 34 nucleo-
tides of identity with the MMTV sequence (ref. 29; Fig. 1).
Both strands were synthesized by using the same doped
mixtures of monomers. The two synthetic products were
labeled with 32P at the 5' end by T4 polynucleotide kinase and
were analyzed by electrophoresis on a 12% polyacrylamide
sequencing gel (Fig. 2A). A 17-mer synthesized under the
same conditions, except that pure phosphoramidites were
used, is shown for comparison. The mutagenized compounds
show faint bands above the major band, possibly related to
mutant sequences of altered electrophoretic mobility or to
infrequent double addition events. Full-length products were
purified by preparative gel electrophoresis, annealed, and
ligated to M13 mpll that had been digested with HindIII and
Sst I. After ligation, the preparation was digested with a
mixture of Sal I and BamHI to select against any uncut or
religated molecules of the M13 mpll vector. This material
was used to transfect competent E. coli by the Hanahan
method, and an amplified library of phage particles was
obtained from =5000 transfection events. An equivalent
transfection using vector religated in the absence of the
synthetic GRE gave only six plaques, indicating that selec-
tion against the parental vector was very effective.
Substitution of the wild-type synthetic GRE sequence for
the HindIII/Sst I portion of the M13 mpll polylinker results
in a net deletion of 3 base pairs. The inserted sequence does
not contain any termination codons in the lacZ reading frame.
Consequently, we expected the wild-type and most GRE
mutants to give blue plaques in the standard a-complemen-
tation assay (20). Approximately 90% of the phage in the
amplified library gave blue plaques. When 10 white plaques
were analyzed by sequencing, all contained substitution
mutations that produced either a TAA or a TGA termination
codon in the lacZ reading frame, or else a frameshift.
Plaques were picked at random from this library, phage
DNA was prepared from small cultures, and the sequences of
the inserted oligonucleotides were determined by the chain-
termination method. A typical gel is shown in Fig. 2B. So far
we have sequenced 546 isolates. All of these contain the
synthetic GRE; 224 of these are wild-type in the sense that
they contain the original MMTV sequence (Fig. 1). The
remainder contain one or more mutations. These results are
summarized in Fig. 3 and Table 1.
Although the cohesive termini of the synthetic GRE were
mutagenized at the same level as the remainder of the
molecule, we expected that mutations in these sequences
would not be efficiently cloned. It is apparent from inspection
of Fig. 3 that there is a low yield of mutations that alter the
HindIII and Sst I restriction sites. In the following analysis,
we will consider the central 30 nucleotides, excluding these
sites, as the "mutagenic target." This target corresponds to
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nucleotides 6-35 of Fig. 3, or -163 to -192 of the MMTV
sequence (27).
We have passed several landmarks in the analysis of GRE
mutations from the library. First, mutations at all 30 positions
were identified. Next, single substitution mutations were
identified at all 30 positions. At least two ofthe three possible
single mutants have now been identified at every position
within the target. Altogether we have observed 88 of the 90
possible substitution mutations. Of these, 74 have been
recovered as single mutants. The 16 mutations that have not
yet been recovered as single mutants are indicated in Fig. 3.
It is interesting that the two mutations we have not yet
recovered, even in multiple mutants, lie at one end of the
target (C-*G at position 33 and T-*G at position 34; num-
bering refers to Fig. 3). Consequently, we have recovered all
possible substitution mutations in the 27-nucleotide stretch
numbered 6-32 in Fig. 3.
The method described here should, in principle, yield a
completely random collection of point mutations. We have
been interested in assessing how closely this expectation is
met. Since the level of impurity in the phosphoramidites used
in the GRE synthesis is 1/20 (5%), we expected an average
of 1.5 substitutions per oligonucleotide in the 30-nucleotide
target region. If each mismatch is either repaired randomly in
vivo or resolved to a homoduplex by DNA replication, then
the expected number of substitution mutations per clone is
the same (1.5). The observed number, 0.83 (453 substitutions
per 546 clones), is somewhat lower. The distribution of these
mutations among the clones fits a random distribution, as
estimated from the Poisson approximation, within statistical
sampling error (Table 1). We do not know the reason for the
lower than expected yield of mutations, and we do not yet
know whether it is a general phenomenon or just a property
of this particular GRE mutant library. Possible explanations
include (i) selection for wild-type sequences at the annealing
step, and (ii) lethal effects of mismatch repair. However,
these mechanisms would not necessarily yield a population of
mutants that so closely fits the Poisson distribution. A
different type of explanation involves inactivation of the
FIG. 1. Design and cloning of the synthetic GRE. The coding strand of
the wild-type MMTV sequence (27) is shown. Numbering of the sequence
is relative to the start of transcription, according to ref. 27. Dashes above
the sequence indicate residues protected from DNase I, by binding of
receptor, for the coding (upper dashes) and noncoding (lower dashes)
strands (14, 15). Asterisks represent the positions of guanine residues
protected from methylation by receptor binding and, conversely, whose
methylation abolishes receptor binding (28). The wild-type MMTV se-
quence is aligned with two functional GRE constructs: (i) a deletion of
sequences 5' to position -193 with the MMTV promoter fused to the
thymidine kinase gene of herpes simplex virus (HSVTK) (17) and (ii) a
deletion of56 base pairs (-104 to -160) fused to the (3-galactosidase coding
region (19). Both strands, GRE.1 and GRE.2, of the synthetic mutagenized
GRE sequence are shown. The cloning strategy is diagrammed.
small amounts of phosphoramidites used as dopant, by
moisture at the time of mixing.
Twelve chemically distinct types of misincorporation
events could occur during synthesis of the GRE (3 different
misincorporations for each of the 4 bases). Since we cannot
determine which synthetic strand contributed a particular
mutation, we are only able to distinguish six classes of
transition and transversion mutations (Table 2). All six
classes are observed. One class, the A*T-*G*C transition,
was recovered somewhat less frequently than expected if all
substitutions are equally likely.
In addition to the expected substitution mutations, 14
single base insertions, and 6 single base deletions have been
observed (Fig. 3). We do not know whether these were
induced during chemical synthesis or in vivo. It should be
noted, however, that they may be simply explained as errors
during chemical synthesis. Each of the observed insertions
could arise by double addition during a single synthetic cycle.
If the phosphoramidite preparations contained a small
amount of material unprotected by a trityl group at the 5'
terminus, then such events could occur. The deletion events
could be explained in two ways. If detritylation is incomplete
then molecules bearing a 5' trityl group would be unable to
couple in one synthetic cycle, but they could participate in
subsequent cycles. Alternatively, deletions could be ex-
plained as a result ofinefficiency ofthe capping reaction. This
reaction, which acetylates unreacted 5' hydroxyls, is intend-
ed to prevent unreacted molecules from participating in
subsequent cycles of synthesis.
DISCUSSION
In spite of the few unexpected findings described above, it is
clear that the mutagenesis procedure works almost exactly as
planned. More than 95% of the mutations are substitutions,
and we have not noticed any feature that differs significantly
from random expectation by more than 2-fold.
The Statistics of Complete Mutational Libraries. We were
interested in calculating the number ofmutations that must be
712 Genetics: Hutchison et al.
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FIG. 2. (A) Gel analysis of mutagenized synthetic oligonucleo-
tides. Mutagenized oligonucleotides (0.1 pmol) GRE.2 (lane 1, length
32) and GRE.1 (lane 2, length 40) were 32P-labeled, using T4
polynucleotide kinase, and fractionated on a 12% polyacrylamide
gel. An unmutagenized oligonucleotide oflength 17 was also included
for comparison (lane 3). (B) Sequence analysis ofGRE mutations. A
sequencing gel showing 12 isolates (isolate numbers g620-g631) from
the GRE mutant library is shown. The wild-type GRE sequence is
indicated to the left of the autoradiogram. Numbering is the same as
that used in Fig. 3. Each set of sequence lanes is arranged ACGT, left
to right. Arrowheads mark those bands corresponding to mutations.
Three sequences are wild type (lanes 1, 6, and 9), seven are single
mutants [lanes 2 (T- A at position 8), 3 (C--HG at position 16), 4 (A--T
at position 15), 5 (T-OG at position 19), 7 (T-.HG at position 8), 11
(T- HG at position 8), and 12 (C-*T at position 33)], one is a double
mutant [lane 8 (T- HG at position 4 and C--HG at position 26)], and one
is a triple mutant [lane 10 (T--G at position 8, A-GG at position 24,
and A--T at position 25)].
analyzed to obtain a complete set of all possible substitution
mutations. If the number of possible independent mutations
is s, then the probability P(1), that one particular mutant will
be present among N analyzed is given by an expression
equivalent to that described for "representative" genomic
libraries by Clarke and Carbon (30):
P(1) = 1 - [1 - (1/s)]N. [1]
By an extension of this reasoning, the probability P, that all
s independent mutations occur within a set ofN selected at
random may be calculated as a product of s terms:
i=N-s+ 1
P= H [1-(1 -1/s)1]. [2]
i=N
Since calculation of this expression is time consuming for
large values of s, an approximation is useful. For values ofN
that are large compared to s, P may be approximated as:
P = [1 - (1 - 11S)N-sl2]s [3]
This expression may be rearranged to give an estimate ofN
in terms of P and s:
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FIG. 3. Distribution of mutations in the synthetic GRE. The
polarity of the sequence shown is that read from the sequencing gel
(Fig. 2B), and it is the bottom strand (GRE.2) of the synthetic GRE
diagrammed in Fig. 1. The total number of substitution mutations at
each position is plotted. Substitution mutations that have not been
recovered as single mutants are listed below the sequence (Singles to
find). The two substitution mutations that have not been observed
within the 30-nucleotide target region (see text) are underlined (C-OG
at position 33 and T- G at position 34). Single bases may be inserted
to the left of the positions indicated to give the observed insertion
mutant sequences. The number of isolates of each insertion and
deletion mutation are indicated below the mutant base in
parentheses.
Fig. 4 depicts the probability ofcompleteness as a function of
the size (N) of a collection of mutants. The parameter s may
refer to the size of any set of independent equally probable
classes of mutants. This analysis may be applied to the case
of the 30-nucleotide GRE target as follows. About 200
mutations must be sequenced to give a probability of95% that
mutations at all 30 positions within the GRE target sequence
would be observed. Since there are 0.83 substitution muta-
tions per clone, this would require sequencing -240 clones.
Similarly, 200 single mutants would give a 95% probability of
including single mutants at all 30 positions. Since 40% of the
clones are single mutants (Table 1), 500 clone sequences
would meet this criterion. The same expression may be used
to show that =700 mutations (850 clones) must be analyzed
to give a 95% probability of identifying all 90 possible
substitution mutations. Analysis of 500 mutations (600
clones) gives about an even chance (56%) of identifying all 90
possible substitutions.
The reasoning outlined above also applies to multiple
mutations. There are 3915 possible double mutations in the
GRE target [(90 x 87)/2]. To achieve a 90% chance of a
complete set of doubles, a library would need to contain
Table 1. Mutation frequency in the synthetic GRE
Substitution Number of clones
mutations Numberofclones
in clone Observed Predicted*
0 224 (41%) 238 (44%)
1 218 (40%6) 198 (36%)
2 81 (15%) 82 (15%)
3 19 (3%) 23 (4%)
4 4 (0.7%) 3 (0.9o)
This table is based on the sequences of 546 clones, containing 453
substitution mutations (0.83 mutations per clone).
*Predicted by Poisson analysis.
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Table 2. Summary of 453 substitution mutations isolated from
the synthetic GRE library
To
From C-G G-C AT T-A Total
(8) C-G 38 57 50 145
(22) A-T 111 73 124 308
==44,000 double mutants. Since our library contains about
15% double mutants (Table 1), a library constructed from the
same mutagenic synthesis would require a minimum of
roughly 300,000 independent clones to meet this criterion.
This should be readily achievable.
Future Prospects. The complete collection of single sub-
stitution mutations in the GRE ofMMTV described here, will
be useful for both in vitro and in vivo analysis of GRE
function. One approach is to assay the mutant sequences for
in vitro glucocorticoid receptor binding activity. Preliminary
evidence (P. Scheible and J. Cidlowski, personal communi-
cation) indicates that the synthetic wild-type sequence cloned
in M13 binds receptor as efficiently as when embedded in the
normal MMTV context. We have constructed an M13-based
vector to assay biological activity of the mutants in vivo. The
synthetic GRE can be conveniently inserted into this vector
upstream from the MMTV promoter fused to the coding
sequences of the chloramphenicol acetyl transferase (CAT)
gene.
The methodology used in this work could be directly
applied to analyze a wide variety ofregulatory sequences that
are small enough to be easily synthesized. The most conve-
nient cases would be those in which the mutants could be
functionally assayed directly in a (perhaps modified) M13
vector. In the case of longer sequences, such as large protein
coding genes, the mutagenic target could be synthesized as a
series of "cassettes." Each would be synthesized in both a
wild-type and a mutagenized form, so that they could be
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FIG. 4. Probability of completeness of a collection of random
mutations. The probability (P) of completeness of a collection of N
mutations was calculated from Eq. 2 (or Eq. 3 in cases in which the
difference is less than the resolution ofthis figure). Curves are plotted
for several different values of s, the size of a complete set of equally
probable mutations.
amount of sequencing necessary to catalog a mutant collec-
tion of the desired level of completeness.
Although we were interested in obtaining single substitu-
tion mutations in the present study, for many purposes
multiple mutations may be of interest. This could, of course,
be readily achieved simply by adjusting the composition of
the mutagenic phosphoramidite mixtures. One such applica-
tion would be to generate a library of multiple mutants from
which interesting clones could be identified by biological
selection. This approach could be applied to regulatory
sequences in DNA, and also to genes for RNA and protein
products.
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